Researchers Develop Algae-Based Microrobots for Targeted Medical Delivery
Biomedical engineers are testing microscopic robots made from algae and nanoparticles that can be guided by light to deliver medicine inside the body. The approach uses living single-celled organisms instead of synthetic motors to reach small blood vessels and organs.
naturalnews.comBiomedical engineers at the University of California, San Diego are developing microrobots that combine living algae with synthetic nanoparticles to move through the body and deliver medicine. The devices use the natural swimming motion of Chlamydomonas reinhardtii algae, which can be directed with blue light and dispersed with red light.
Joseph Wang and Liangfang Zhang led the project, attaching drug-carrying nanoparticles to the algae membranes through electrostatic force. In laboratory tests, the researchers formed the algae into shapes such as circles and squares by projecting light through patterned screens.
The same method is being studied for stomach applications using acid-resistant algae collected from mining sites. Researchers are also testing algae-based microrobots to absorb or neutralize toxins in rivers and oceans by coating them with reactive chemicals.
Other groups are examining fully synthetic microrobots for removing plastic waste from marine environments. The work replaces earlier concepts of tiny mechanical devices with systems that rely on biological propulsion. >"Algae just swims and swims.
Key Facts
Story Timeline
2 events- Recent laboratory tests
Researchers formed algae swarms into shapes using patterned blue light.
1 source@NewScientist - Ongoing work
Nanoparticles were attached to algae for drug transport and toxin absorption.
1 source@NewScientist
Potential Impact
- 01
Targeted drug delivery could reduce required dosage amounts in some treatments.
- 02
River and ocean decontamination trials may expand if algae systems prove effective.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.